Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- Isotope Science and Enrichment Directorate (6)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate
(128)
- User Facilities (27)
Researcher
- Edgar Lara-Curzio
- Steven J Zinkle
- Yanli Wang
- Ying Yang
- Yutai Kato
- Adam Willoughby
- Bishnu Prasad Thapaliya
- Brandon Johnston
- Brian Sanders
- Bruce A Pint
- Charles Hawkins
- Charlie Cook
- Christopher Hershey
- Craig Blue
- Daniel Rasmussen
- Eric Wolfe
- Frederic Vautard
- James Klett
- Jerry Parks
- John Lindahl
- Marie Romedenne
- Nidia Gallego
- Rishi Pillai
- Tim Graening Seibert
- Tony Beard
- Weicheng Zhong
- Wei Tang
- Xiang Chen

V-Cr-Ti alloys have been proposed as candidate structural materials in fusion reactor blanket concepts with operation temperatures greater than that for reduced activation ferritic martensitic steels (RAFMs).

With the ever-growing reliance on batteries, the need for the chemicals and materials to produce these batteries is also growing accordingly. One area of critical concern is the need for high quality graphite to ensure adequate energy storage capacity and battery stability.

Test facilities to evaluate materials compatibility in hydrogen are abundant for high pressure and low temperature (<100C).

The technologies provide a system and method of needling of veiled AS4 fabric tape.

A bonded carbon fiber monolith was made using a coal-based pitch precursor without a binder.

The first wall and blanket of a fusion energy reactor must maintain structural integrity and performance over long operational periods under neutron irradiation and minimize long-lived radioactive waste.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).